Founded
Address
ARCH Venture Partners
1700 Owens Street
Suite 535
San Francisco, CA 94158
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 30599
Corporate information
Official name
ARCH Venture Partners LP
Registration country
Company type
Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startupFunding rounds
Top investment portfolio themes
accelerator (1)
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 136Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Receptos Inc [] | N/A | |||||
Sapphire Energy Inc | N/A | |||||
Semprius Inc | Developer of low cost, high performance concentrator photovoltaic modules to make solar power generation economically viable in sunny, dry climates. | Venture | ||||
Semprius Inc | Developer of low cost, high performance concentrator photovoltaic modules to make solar power generation economically viable in sunny, dry climates. | Series C | ||||
Semprius Inc | Developer of low cost, high performance concentrator photovoltaic modules to make solar power generation economically viable in sunny, dry climates. | Series B | ||||
Semprius Inc | Developer of low cost, high performance concentrator photovoltaic modules to make solar power generation economically viable in sunny, dry climates. | Series A | ||||
SilverStorm Technologies Inc | High-performance interconnect fabrics for cluster & grid computing | N/A | ||||
Sorbent Therapeutics Inc | N/A | |||||
Surface Logix Inc | N/A | |||||
Teach.com | N/A | |||||
Theraclone Sciences Inc | Series B | |||||
Theraclone Sciences Inc | Venture | |||||
Therus Corp | N/A | |||||
Trubion Pharmaceuticals Inc | N/A | |||||
Univa Corp | N/A | |||||
Variation Biotechnologies (US) Inc | A vaccine development company dedicated to the innovative formulation | N/A | ||||
VentiRx Pharmaceuticals Inc | N/A | |||||
Viathan Corp | N/A | |||||
VLST Corp | N/A | |||||
Xtera Communications Inc | N/A | |||||
908 Devices Inc | Series B Follow-on investment | |||||
908 Devices Inc | Series A Initial investment | |||||
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | ||||
Adesto Technologies Corp | Fabless semiconductor manufacturer | N/A | ||||
Alfalight Inc | Designer and manufacturer of high-power diode lasers for the industrial, defense and telecommunications markets. | N/A |